← Leaderboards
T. Andrew Taton
University Of Minnesota Twin Cities
$1,485,147
Attributed
$1,485,147
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $274.4K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,485,147 · 2
By mechanism
R01$995,282 · 1
R21$489,865 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Chang W Song$2,892,559
- Emad S Ebbini$3,808,641
- Robert James Griffin$2,994,864
- Kalpna Gupta$21,163,908
- James B. McCarthy$6,723,063
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseEngineeringEpitopesIl2ra GeneAntibodiesAvidityActivated Protein C ReceptorEffectivenessExpectationFight AgainstApoptosisCd4 Positive T LymphocytesCd8b1 GeneCellsBaseAntigen-Presenting CellsBehaviorClinical TrialsBinding (Molecular Function)Adenomatous Polyposis Coli ProteinAntigensDesignCancer VaccinesImmune System
Grant awards (7)
Nanostructured Cancer Vaccines$174,162
R01 · FY2010 · CA · contact PI
Nanostructured Cancer Vaccines$274,364
R01 · FY2009 · CA · contact PI
Nanostructured Cancer Vaccines$273,231
R01 · FY2008 · CA · contact PI
Nanostructured Cancer Vaccines$273,525
R01 · FY2007 · CA · contact PI
Magnetomicelle Nanoparticles for Triggered Drug Delivery$162,458
R21 · FY2006 · EB · contact PI
Magnetomicelle Nanoparticles for Triggered Drug Delivery$163,331
R21 · FY2005 · EB
Magnetomicelle Nanoparticles for Triggered Drug Delivery$164,076
R21 · FY2004 · EB